Morphological basis for the assessment of steatosis, steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease associated with obesity and pathology of the biliary tract
Journal Title: Гастроентерологія - Year 2017, Vol 51, Issue 3
Abstract
Background. The purpose was to study the histopathological features of steatosis, steatohepatitis and liver fibrosis in fatty liver disease of non-alcoholic etiology and to establish the linkages between the degree of steatosis, histological markers of fibrosis and increase of body mass index (BMI) in patients with non-alcoholic hepatic steatosis (NAHS) and non-alcoholic steatohepatitis (NASH) associated with obesity and pathology of the biliary tract. Materials and methods. The study included 70 patients with non-alcoholic fatty liver disease (NAFLD), including 48 individuals with NAHS combined with obesity (group 1), and 22 patients with NASH and obesity (group 2). Depending on the degree of increase in BMI, patients with NAHS, NASH and associated obesity were divided into three groups: BMI 25–29.9 kg/m2 — overweight; BMI 30–34.9 kg/m2 — I degree obesity; BMI 35–39.9 kg/m2 — II degree obesity. For histological diagnosis of NAHS/NASH, as well as to determine the stage of liver fibrosis, we used МЕТАVIR and BRUNT criteria. Results. The dependence of the severity of hepatic steatosis on BMI was detected in patients with different clinical forms of fatty liver disease, which was confirmed by the results of correlation analysis: NAHS — rs = 0.798 (p < 0.001), NASH — rs = 0.678 (p < 0.001). With increasing BMI, fibrous processes are exacerbated, from the presence of F0 stage in overweight patients with NAHS to F3 stage in II degree obesity in patients with NASH. The coefficients of correlation between BMI and the stage of liver fibrosis are: in NAHS — rs = 0.464 (p < 0.001), in NASH — rs = 0.759 (p < 0.001). Conclusions. In most cases of NAHS (58.3 %) and NASH (45.4 %,) macrovesicular steatosis was identified. Patients with NAHS more often had F1 and F2 fibrosis stages (50.0 %), while patients with NASH — F2 and F3 stages of fibrosis (77.3 %). Mixed type of liver fibrosis is characteristic of the comorbid course of NAFLD.
Authors and Affiliations
Yu. M. Stepanov, A. Yu. Filippova
Keywords
Related Articles
- EP ID EP231301
- DOI 10.22141/2308-2097.51.3.2017.112636
- Views 74
- Downloads 0
The Role of Bismuth in the Treatment of Gastroduodenal Pathology (Literature Review and Own Researches)
The article presents the history of colloidal bismuth subcitrate and considers the basic mechanisms of its effects on the gastric mucosa, both cytoprotective and anti-helicobacter. The recent data of the worldwide resear...
Modern Methods for Detecting Liver Fibrosis
A liver fibrosis is the basic element in the development of pathological processes in the liver tissue, and fibrosis degree is a specific sensitive enough marker in case of pathological changes in the liver under the inf...
Clinical and Anamnestic Features of Hepatic Steatosis in Children
The article is devoted to the study of clinical and anamnestic features of hepatic steatosis in children. The results of a comparative analysis of survey data of patients with evidence of hepatic steatosis and patients w...
Metabolic therapy in the comprehensive treatment of patients with comorbidity of chronic pancreatitis and stable coronary artery disease
Metabolic therapy is one of the few ways to restore normal functions of all the vital organs and systems. The goal of the research was to explore the effectiveness of a course of treatment using metabolic drug Vazonat (m...
Functional Features of the Pancreas during Chronic Pancreatitis
Aim of study: to identify functional status of pancreas in patients with chronic pancreatitis depending on the stage of fibrotic transformation and activity of parenchymal inflammation. Materials and methods. The preoper...